Thursday, 8 March 2018

It is time to Reschedule Cannabis

The use of cannabis for medicinal purposes is common and the evidence that it is efficacious for several medical conditions is now very strong: Medical Evidence

It is illogical to continue categorising the drug under Schedule 1 of the Misuse of Drugs Act.


Schedule 1 Drugs:

Drugs belonging to this schedule are defined as having no therapeutic value and therefore cannot be lawfully possessed or prescribed. These include LSD, MDMA (ecstasy) and cannabis. Schedule 1 drugs may be used for the purposes of research but a Home Office licence is required.


One of the main impacts of this schedule that is that it makes doing research into the benefits of cannabis all but impossible for most. I saw this for myself whilst working at Cancer Research UK in 2013 to investigate the oncological potential for cannabis: The project had a budget of £150k and would take approximately 2 years to complete. However, once the time and costs to get a license along with the required security needs had been added along with the time it would take to source the exact materials/cannabis required for the project had been added; the project would now take more than 4 years and would cost £315k! So the project was rejected - this has been happening all over the UK and for many years.

In addition, Schedule 1 means that doctors can neither be officially taught about the benefits of cannabis nor discuss consumption with patients other than in order to warn them of the dangers or else risk losing their license to practise. Afterall - since the schedule defines cannabis as having no recognised therapeutic use - why would doctors (or patients) need to know anything about it?

There is a similar impact on government departments as well as registered charities who both risk their licenses if they engage on the subject openly which is why it took so long for and charities to come out publicly in support of cannabis as medicine: A very big "Thank you" to The MS Society for their courage. We hope more will follow....but you can bet they will, the moment cannabis is out of schedule 1!

Watch this great little clip produced by The Beckley Foundation on the inconsistency of our current scheduling of cannabis:

The UK is the world's largest producer and exporter of legal cannabis for medical and scientific use. Yet its drug laws are inconsistent and contradictory, criminalising thousands of patients who use it to treat chronic conditions.


Schedule 2 or Schedule 4?

Release have a really good article that details the differences between the schedules.

Being that the only current approved cannabis medicine, Sativex, is currently in Schedule 4(i), this would seem the most logical and sensible place to put cannabis too, and if it were up to me, or up to most informed opinion, then this is what should happen, but the proposal from Paul Flynn's Elizabeth Brice Bill is proposing only the smallest of changes which would place cannabis into Schedule 2.

Here is the entire text of the Bill:

Rescheduling of cannabis and cannabis resin
The Misuse of Drugs Regulations 2001 are amended as follows.

In paragraph 1(a) of Schedule 1, omit “Cannabis (not being the substance specified in paragraph 5 of Part 1 of Schedule 4) and cannabis resin”.
In paragraph 1 of Schedule 2, after “Bezitramide”, insert “Cannabis (not being the substance specified in paragraph 5 of Part 1 of Schedule 4) and cannabis resin”.

Why not Schedule 4 like Sativex?

In 2012 Schedule 4 was split into 2 parts (i) and (ii) so that certain medicines, such as Sativex and benzodiazapines, could be more strictly controlled without making them so difficult for doctors to prescribe due to all the approvals, documentation and licenses required for Schedule 2 substances. Since this point in time, from a legal and possession standpoint, Schedule 2 and Schedule 4(i) are now the same:

Schedule 4(i) drugs can only be lawfully possessed under prescription. Otherwise, possession is an offence under the 1971 Act.
So in actual fact, Sativex, without a prescription is treated as a schedule 2 substance

Ok - so what about all the approvals, documentation and licenses required for doctors to be able to prescribe - surely this will seriously restrict access and discourage doctors from prescribing?

Well until a few months ago, this would have been true, however, since some of the more powerful opioid derivatives such as Fentanyl and Carfentanyl were added to Schedule 2, it was necessary to make some changes to the way this worked too, or else many thousands of patients in the UK would lose access to their pain relief. So the process for doctors wanting to prescribe a schedule 2 substance was significantly simplified and automated and can now be done with a few clicks of a mouse.

The upshot of all of this is that to all intents and purposes, the only difference between Schedule 2 and Schedule 4(i) is that there is an obligation to record and track prescriptions which, frankly, would be a huge benefit for cannabis, as we really don't currently have all the patient data we need and this will help us gather it.

So whether cannabis is moved to Schedule 2 or Schedule 4(i) makes little or no difference and the only practical difference being data collection, this is a benefit to the future of cannabis as medicine in the UK.

What does this mean for Legal Access to Cannabis Therapeutics

Once cannabis has been moved out of schedule 1, it becomes possible for doctors to be able to legally write prescriptions for cannabis and with a few minor tweaks to a few import regulations (no law change involved) for those prescriptions to be fulfilled at a licensed pharmacy. In terms of what forms of cannabis would be available will depend on future policy in the UK but now that there are so many suppliers/producers of quality cannabis medicines in all forms, such as Flower or bud and cannabis oils, extracts and edibles and from international cannabis pharmaceutical companies like, Bedrocan in the Netherlands, Tikum Olam in Israel, Columbia Care in the US, Tilray in Cananda with more and more coming on board all the time there is certainly little need to fear too limited a range of products, though it might be fair to suggest that in the UK, we may start with just a few and increase the range as time goes by. But, to reiterate, this is speculation at this stage and the question is unlikely to be addressed before or even alongside rescheduling.

How will the effect patients who choose to Grow Their Own Cannabis?
None of this will have any direct impact of those of us who choose to grow and produce our own cannabis medicine. Whether in Schedule 2 or in Schedule 4(i) - the situation is identical to the end consumer or grower - However - there is cause for some hope here too, thanks to the quite unique limitations on how our police force operates in conjunction with the Crown Prosecution Service (CPS)

Imagine, for a moment, that sometime after patients in the UK can legally access and consume a cannabis flower product, by prescription. Then imagine 3 cannabis consumers in a room.

Person 1 is in possession of Bedrocan (cannabis flower) and is consuming that.
Person 2 is in possession of some street weed they just bought and is consuming that.
Person 3 has some they grew themselves and is consuming that.
If those 3 people stay quiet when the police are called to the scene - they are not going to know, who is doing something illegal and who is not, based on sight alone and as such, can no longer make a "safe" arrest. Reasonable suspicion is no longer reasonable!

There are legal teams and QCs looking into this as I write this article, but the likely upshot of this could be that once legal forms of flower have been introduced into the UK, personal possession and even personal GYO could become tacitly and logistically decriminalised. Of course, as above, we will not be able to get a definitive answer on this, until after it has happened and the first "test case" happens.

In any and all eventualities and no matter what sort of future any of us want for cannabis in the UK, absolutely nothing can or will change without moving it from Schedule 1 of the Misuse of Drugs Act, and even the smallest of changes to Schedule 2 has hugely positive implications, which I strongly suggest is the very first domino to fall which will cause, over time, all the rest to fall too.

Jon Liebling

Political Director - United Patients Alliance



Tuesday, 27 February 2018

UK cannabis market dominated by high-potency ‘skunk’

EMBARGO: 2230 GMT Tuesday 27 February 2018

UK cannabis market dominated by high-potency ‘skunk’

The first comprehensive survey of cannabis strength published in the UK for almost 10 years finds that high-potency varieties made up 94% of police seizures in 2016. The study, co-authored by King’s College London researchers, highlights the potential threat posed to mental health by a market dominated by strong cannabis.

Researchers analysed almost a thousand police seizures of cannabis from London, Kent, Derbyshire, Merseyside and Sussex. The same areas were last sampled in 2005 and 2008.  In 2016, 94% of police seizures were high-potency sinsemilla, also known as ‘skunk’, compared to 85% in 2008 and 51% in 2005.

‘In previous research we have shown that regular users of high-potency cannabis carry the highest risk for psychotic disorders, compared to those who have never used cannabis,’ says senior author Dr Marta Di Forti, MRC Clinician Scientist at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience.

‘The increase of high-potency cannabis on the streets poses a significant hazard to users’ mental health, and reduces their ability to choose more benign types,’ says Dr Di Forti.

The study, published today in the journal Drug Testing and Analysis, found the dominance of sinsemilla was mainly due to a sharp reduction in availability of weaker cannabis resin; from 43% in 2005 and 14% in 2008, to just 6% in 2016 but as low as 1% in the London area.

The average concentration of THC -  the main psychoactive component of cannabis – in resin also increased from 4% to 6%. The average concentration of THC in sinsemilla has remained at 14% between 2005 and 2016.

Historically, cannabis resin has been rich in cannabidiol (CBD), which is almost entirely absent from sinsemilla. Due to its antipsychotic activity, CBD may potentially moderate some of the effects of THC. However, changes in the source of cannabis plants used for resin has led to a drop in CBD content. In 2005 and 2008, the ratio of THC to CBD was 1:1, whereas in 2016 the ratio was 3:1.

recent King’s College London study found the first evidence for a relationship between increases in cannabis potency and first-time admissions to drug treatment, using data from the Netherlands. The research team are now investigating whether changes to the cannabis market in the UK are having a measurable impact on mental health.

Dr Di Forti, whose research into the mental health impacts of cannabis is funded by the Medical Research Council, says ‘More attention, effort and funding should be given to public education on the different types of street cannabis and their potential hazards. Public education is the most powerful tool to succeed in primary prevention, as the work done on tobacco use has proven.’

NOTES TO EDITORS

Paper reference

‘Potency of Δ9–tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology’, Potter et alDrug Testing and Analysis, DOI: 10.1002/dta.2368

Contact

For a copy of the paper, to interview Dr Marta Di Forti or for further media information please contact: Robin Bisson, Senior Press Officer, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, robin.bisson@kcl.ac.uk / +44 20 7848 5377 / +44 7718 697176.

About King’s College London kcl.ac.uk

King's College London is one of the top 25 universities in the world (2017/18 QS World University Rankings) and among the oldest in England. King's has more than 26,500 students (of whom nearly 10,400 are graduate students) from some 150 countries worldwide, and nearly 6,900 staff. The university is in the second phase of a £1 billion redevelopment programme which is transforming its estate.

King's has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF) King’s was ranked 6th nationally in the ‘power’ ranking, which takes into account both the quality and quantity of research activity, and 7th for quality according to Times Higher Education rankings. Eighty-four per cent of research at King’s was deemed ‘world-leading’ or ‘internationally excellent’ (3* and 4*). The university is in the top seven UK universities for research earnings and has an overall annual income of more than £600 million.

King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.
King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit: kingshealthpartners.org.

About the Medical Research Council

The Medical Research Council is at the forefront of scientific discovery to improve human health. Founded in 1913 to tackle tuberculosis, the MRC now invests taxpayers’ money in some of the best medical research in the world across every area of health. Thirty-two MRC-funded researchers have won Nobel prizes in a wide range of disciplines, and MRC scientists have been behind such diverse discoveries as vitamins, the structure of DNA and the link between smoking and cancer, as well as achievements such as pioneering the use of randomised controlled trials, the invention of MRI scanning, and the development of a group of antibodies used in the making of some of the most successful drugs ever developed. Today, MRC-funded scientists tackle some of the greatest health problems facing humanity in the 21st century, from the rising tide of chronic diseases associated with ageing to the threats posed by rapidly mutating micro-organisms. www.mrc.ac.uk


Robin Bisson
Senior Press Officer
Institute of Psychiatry, Psychology & Neuroscience, King's College London 

@KingsIoPPN

Wednesday, 21 February 2018

PP2 Press Release


MEDIA ADVISORY
Paul Flynn MP’s cross party support builds ahead of second reading of Elizabeth Brice Bill for the legalisation of cannabis for medical use
Supporters include Caroline Lucas MP, Crispin Blunt MP, Frank Field MP & Layla Moran MP
Friday 23 February 2018
3pm GMT
Parliament Square, London

On Friday 23 February 2018, the United Patients Alliance (UPA) will hold a protest in front of the Houses of Parliament in Westminster, as Paul Flynn MP and UPA patron introduce the second reading of the Elizabeth Brice Bill for the legalization of cannabis for medicinal purposes.

The Bill has growing cross party support from MP’s including Caroline Lucas (Green and UPA Patron), Layla Moran (Lib Dem and UPA Patron), Tonia Antoniazzi (Lab and UPA Patron), Frank Field (Lab), Mary Glindon (Lab), Jeff Smith (Lab), Kelvin Hopkins (Lab), Crispin Blunt (Con), Michael Fabricant (Con), Martyn Day (SNP), Ronnie Cowan (SNP), Alastair Carmichael (Lib Dem)

Last year, on 10 October 2017, as Paul Flynn introduced the first reading of the Bill, the UPA held a ‘cannabis tea party’ outside the HoP to stimulate critical debate on the need to allow access to the drug for patients suffering chronic pain conditions. At 3pm this Friday after the second reading of the Bill, Paul Flynn will join the UPA outside the HoP to reveal  the outcome. If the Bill is passed it will proceed to committee stage and into law within just a few weeks or months

Available for interview and photo opportunity | Friday 23 February 2018, 3pm

Who:                    Paul Flynn, Labour MP for Newport West and UPA patron
Jon Liebling, UPA Political Director. Consumes cannabis to relieve symptoms of depression and anxiety
Alex Fraser, UPA Co-Founder. Crohn’s patient who consumes cannabis to relieve his symptoms
Clark French, UPA Co-Founder. Multiple Sclerosis patient who consumes cannabis to relieve his symptoms
Faye Jones, UPA Director. Rheumatoid Arthritis patient who consumes cannabis to relieve her symptoms
Abby Moore, UPA Director. Endometriosis Patient who consumes cannabis to relieve her symptoms
+ patient members of UPA and members of the public

When:                  Friday 23 February 2018, 3pm

Where:                Parliament Square
                              Westminster
London SW1P 3JX

Why:                    Cannabis is currently classified as a Schedule 1 drug meaning it is considered to have a high potential for abuse and no recognizable medical application by the Home Office. It is currently illegal in the UK. This illegal status means those who need the drug to manage chronic pain and other symptoms are denied access to it. Thousands of patients in the UK are being forced to break the law by consuming illegal cannabis or growing their own from seeds. The United Patients Alliance (UPA), a patient advocacy group, believes patients in the UK should not be criminalised for using cannabis, and was founded to challenge the injustice of prosecuting individuals who use cannabis to help alleviate their symptoms.

                              Paul Flynn, Labour MP for Newport West, has long been a voice in the call to amend the law to legalise cannabis for medicinal purposes. Most recently in his speech to the Commons in July 2017 he called directly for civil disobedience, calling on people who use cannabis for medicinal purposes to challenge the law and consume cannabis at Parliament.
                             
United Patients Alliance (UPA)
www.upalliance.org
@UPAllianceuk

Press contacts

Rebecca Ladbury: rebecca@ladburypr.com | +44 (0)7941 224 75
Danya Agababian: danya@ladburypr.com | +44 (0)7779 635147


Notes to Editors

About United Patients Alliance (UPA)
The United Patients Alliance (UPA) was founded to call attention to the injustice of prosecuting individuals for treating their chronic conditions with cannabis. Some of the most vulnerable members of  society face up to fourteen years in prison for consuming a medicine that is legal across North America and Europe. Despite the wide body of clinical evidence supporting its use, the UK Government continues to deny patients a medication with a proven record of safety and efficacy. They need to recognise the well-established medical benefits of cannabis. We believe that no one should be criminalised for trying to be well.  Being sick can be an isolating experience, especially if your medicine is illegal and only available on the black market. The United Patients Alliance is here to support patients through tough times and advocate on their behalf for safe and legal access to cannabis.

About Clark French
By consuming cannabis to treat MS instead of pharmaceuticals Clark saves the NHS over £30,000 a year. Clark was diagnosed with MS in 2010 in the final year of his degree at Reading University. Clark has chronic pain, spasms, fatigue, migraines, tremors and finds it hard to stand up. Cannabis improves all of these symptoms. 

"Cannabis helps me to have a much better quality of life than I get on the medications my doctor can prescribe me. I think it is ridiculous that I can legally take opioids and chemotherapy based treatments which could kill me, but am criminalised for consuming cannabis despite the support of my Neurologist, GP, MS nurse and wider health care team. The UK government needs to act on the evidence which shows that cannabis has medicinal value and change the law immediately".

About Alex Fraser
Alex Fraser, 26, has had Crohn’s disease since he was 19 and uses cannabis to relieve his symptoms. Cannabis stimulates his appetite, reduces his pain dramatically and helps with sleep. It also helps Alex to keep his weight up, and without it he fears he may waste away and become scarily underweight, as many Crohn’s patients do.

“I have tried not consuming cannabis, and my symptoms always increase dramatically, my pain is worsened and I often can’t sleep or eat without severe discomfort. I also have taken prescription meds, and have tried not taking those, and the difference is minimal. I can safely say that cannabis is the most effective treatment for my Crohn’s disease that I’ve tried. I hope that, with the help of the UPA I can have safe, legal access to it as soon as possible”.

About Jon Liebling
Jon Liebling has suffered with varying degrees of stress migraines, back pain, anxiety and depression for most of his adult life, which he has effectively self-managed with cannabis. 

When left alone by the law, and in every other aspect I have been and am a productive, tax paying, law abiding citizen, father, son and brother who has never done anything to harm anyone, and don't accept why I, or the countless others who benefit, have to suffer more as a result of this uninvited restriction on liberty. From my perspective, the law itself is a crime. Prescription medicine has made me worse. The law has threatened me, hurt me and taken my medicine away. Cannabis has done nothing but help”.







Thursday, 25 January 2018

PRESS RELEASE - UPA Northern Ireland Medical Cannabis Summit 2018



PRESS RELEASE - United Patients Alliance – Northern Irish Medical Cannabis Summit


NO EMBARGO

Event: United Patients Alliance – Northern Irish Medical Cannabis Summit
Date: 27th January 2018, 10:00am – 5:00pm
Venue: Riddel Hall, Queens University, Stranmillis Road, Belfast.
Guests: 150+

Major announcements to be made this week;

  • GreenLight Medicines agreed to sponsor the event. They are Irelands only cannabis based pharmaceutical firm, have been building an extraction plant and laboratory on the border with Co. Tyrone and Co. Donegal.
  • Dr. David Gibson, Northern Irelands only cannabinoid researcher working out of Ulster University will attend and present his recent research conducted right at home.
Conference speaker list to be found below in editorial

Quote from Keynote Speaker: Professor Michael Barnes, MD FRCP, Neuropharmacology,
“The Northern Irish Medical Cannabis Summit is really important to raise awareness of the benefits of medical cannabis and continue our efforts to get this invaluable product legal for thousands of people currently having to live with pain and other real problems in their daily lives.”

Quotes from Patients:
Neil Paine, 46, Coleraine, British Army Veteran 14 years, PTSD and Chronic Pain
“I believe that members of organizations concerned with the care of veterans could gain a much needed insight into this long demonized medicine. The Barnes Report already shows evidence to support the medicinal and therapeutic value of cannabis as treatment for PTSD among other conditions.”

Gareth Tuff, 36, East Belfast, MS Patient using cannabis
(seeking to stand in local council elections next year with the Ulster Unionist Party)
“A governments primary role is to keep its citizens safe. If the medicine is safe and effective and there is general consensus amongst the medical fraternity then there is no question; the law will change. As a Multiple Sclerosis patient I am forced (as there is no other option) to take some very dangerous pharmaceutical infusion medications. The danger is death. Debate not hate, that is what is needed.”

Deborah Hempkin, 55, Newry, Mother of a Chrons Patient using cannabis
“From a mother who was against Cannabis her entire life to watch her son heal within 3 days was hard to believe. I watched my son struggle with Crohns Disease for 14years and I have also watched him heal within 3 days from taking Cannabis. Events like these are of the utmost importance to deliver the truth behind Cannabis and help to educate people.”

Quotes from UPA Directors:
Alex Fraser, UPA Director
“Conferences like this are essential to change the image of cannabis in the mind of the public, to remove the stigma and to educate people about how Cannabis could help them or someone they love"

Jon Liebling, UPA Political Director
"We have been seeing a significant shift around the world over the last few years and indeed in the UK over the last 12 months. UPA Northern Ireland showed at the protest outside Stormont in October that there are things that all political paritnes can agree upon and cannabis as medicine is one. The time is perfect for such a well organised, well attended summit here in Belfast.

Editorial:
United Patients Alliance Northern Ireland are proud to announce the Northern Ireland Medical Cannabis Summit, the regions leading forum for evidence based discussion on cannabis based medicines. To be held in the rather fitting backdrop of Riddel Hall, Queens University.
This conference is a gathering of people at the forefront of cannabis research, policy innovation, legal knowledge and cannabis product and brand development. Ran completely by volunteers, the Northern Irish Medical Cannabis Summit should be in the calendar for anyone planning to engage in the debate in 2018 and beyond.

We will host talks, presentations and panel discussions from;


  • Professor Michael Barnes, MD FRCP, Consultant Neurologist and Neuropharmacologist, Author of The Barnes Report, the UK’s leading body of cannabinoid research.
  • Baroness Molly Meacher, Chairperson to the All Party Parliamentary Group for Drug Policy Reform, Crossbencher House Of Lords
  • Dr. Arno Hazekamp, Cannabis Consultant
  • Dr. David Gibson, Cannabinoid Researcher, Ulster University
  • Paul North, Treatment and Addiction Policy Advisor at VolteFace
  • Kirstie Douse, Release, The UK Centre of Expertise on Drugs and Drugs Law
  • PANEL FROM REPUBLIC OF IRELAND; Dr. Garrett McGovern. TD Gino Kenny, Tom Curran and Brian Houlihan
  • UPA Directors and Regional Chairpersons
One day to promote change

The first of its kind in Northern Ireland. This conference will be a collection of minds at the
forefront of developing sensible evidence-based cannabis policy, regulated cannabis products, progressive policing and first-hand experience with the effects of cannabis prohibition on the healthcare system, legal system and people.
Intended to redistribute knowledge to those in a position to influence future policy, this event will be the first opportunity to receive this level of education from the front lines of cannabis research and policy innovation. The aim of this conference is to redistribute knowledge to those in a position to influence future drug policy reform.
Not only to provide a forum encouraging discussion in a professional and academic context and develop a qualified response to a serious social and health issues but to facilitate liaison between executive bodies and relevant nongovernmental civic input organisation, provide research and evaluate developing frameworks while adopting and enhancing
current collaborative networks that will help with the advancement of policy and its appropriate use by companies, institutions and individuals in Northern Ireland.

All ages are welcome and disabled access is available, tickets cost £21.50 including booking fee free the EventBrite page
ticketing service at www.eventbrite.co.uk/e/northern-irish-medical-cannabis-summit-2018-tickets-41766613064.

The organisers are delighted to reveal that the event is a SELL OUT 

END

Author contact:
Pearse Donnelly
Regional Co-Chairperson UPA Northern Ireland, NIMCS18 Manager
Suite 3, 100 University Street, Belfast, BT7 1HE
E: upanorthernireland@gmail.com
T: 07927093596

Political Director
Jonathan Liebling
E: jon@liebing.co.uk
+447921589237

Wednesday, 3 January 2018

CLEAR's PR Threatening Cannabis Patients - AGAIN



Patients meet with Lynne Featherstone - Feb 2015

How ironic is this picture from a few years ago now. The very first time that I met with CLEAR - Cannabis Law Reform and Peter Reynolds. I learned after this single experience that he was not someone with whom I was going to get along......or trust. It should be noted that in 2017, the entire CLEAR Board resigned and left!

Unfortunately I couldn't post about this directly on Facebook as I had been banned for 3 days for bullying him! So I wrote it in blog form......and he can't stop me tweeting it! :)


Recent Litigation History


After his recent £36k loss from his unsuccessful long term liable litigation against Chris Bovey of NORML UKyou might have thought he would take a rest from threatening more vexatious law suits. 



Alas, no. Peter seems to want to focus his time, effort and resources into attacking more cannabis patients and other reform groups again, instead of actually doing anything constructive about changing the law




You can read all about these from:
1:Sarah McCulloch
2: The Dorset Eye
3: Petey Pays Chris Bovey (Which include more legal threats to a UPA patient/admin)

Are these "vexatious lawsuits" from Peter, actually what the CLEAR subscription is paying for? 


Peter Reports UPA to Facebook - For nothing!

Over the last couple of weeks, Peter Reynolds has been reporting members of United Patients Alliance but particularly myself to Facebook for various things.

Shortly after updating our CBD Product information and recommended suppliers pages (Check them out!), Facebook acted on a complaint (pending investigation) about "Copyright Infringement" for a photo apparently belonging to CLEAR Cannabis Law Reform and reported by Peter Reynolds.

Unfortunately, Facebook's policy appears to be to remove anything that someone complains about first and ask questions later! 
This fabricated complaint is being actively investigated by Facebook on our request....watch this space....



Peter Turns to Twitter

As he had me blocked on Facebook, I did ask Peter,via Twitter, to which photo the complaint was referring, as all photos and logos were approved by the companies on the page? But if there was something we hadn't noticed, then a simple request would suffice. Of course, there is nothing. It's a complete fabrication.

Neither his first, nor second response was helpful:

https://twitter.com/TweeterReynolds/status/942880343140466689


A Happy New Year - From CLEAR!

So - Whilst minding our own business as usual, it seems he had infiltrated and was spying and taking screenshots (see - documentary evidence, in the email) in our private patient forum (does he have no scruples at all? - Spying on a PRIVATE PATIENT forum!) where something else he had said to another patient was under discussion, I and our Founder, Clark French received this threat in an email from Peter, who is described by Cannabis Trades Association Chair, Mike Harlington as "nothing but an adviser". Mike was cc'd. I have not heard whether he supports Peter's threats or not as yet.
You can read an alternative point of view on CTAUK and Peter's "involvement" here: Cannabis Trade Association Scam!




I don't like this sort of "secretive" communication and wanted the conversation out in the open, I posted the text on my own personal timeline on Facebook. 
The post was reported a few moments later for "Bullying" by Peter and I have been banned from posting or using messenger for 3 days.






UPDATED 3rd Jan
Response Received from Mike Harlington of Cannabis Trades Association

As Mike had been copied into Peter's communication even though he apparently has nothing to do with the organisation and only acts as an advisor, and given Peter had now changed his story from the "Copyright" issue being about CLEAR and now it was about CTAUK - I was keen to get some clafirication of their positions in all of this:


As you can see - He chose to ignore that and attempt to discredit individuals (myself) and patients that they had attacked - note how Tom from Canabidol is now copied in too...They seem really keen to keep bringing UPAs appointed trustee Professor Mike Barnes up too - Haven't mentioned him once! Weird!





UPDATED 4th Jan - Peter Claims Stock Photo and Boris's Bus as his own - sort of?

So first off, apparently this is the photo that is "owned" by CLEAR or CTAUK (he can't seem to make up his mind) - But since it is a free stock photo that has been used by CBD companies and articles for years - seems a bit rich to suddenly claim it as your own and try to sue others for using it - Peter - That's NOT how the internet works......



But not only that - he goes on to make a claim that Boris's bus, was indeed HIS idea too - Sorry Peter, but you will have to take that up with Boris - I think you will find they did it before you did! (You're not related to the current President of the US are you?)



And finally he wants to try to blame United Patients Alliance for some comments someone from 'The Community' made on one of HIS blog entries. Please note that 'The Community' is not a UPA account or forum.  I do not know who they are. The internet doesn't work like this either!




Besides a number of threats of legal action Peter has made against me personally and Clark, he has also threatened other UPA Patients and Directors.
Some might think that this is some sort of entertaining game but the patients that he abuses and threatens would not agree and whilst I have done my level best to ignore it, now that UPA and our patients are being actively targeted - enough is enough.  



All of this happened to our founder and MS patient, Clark French, along with a few others (Read Sarah's blog above too!) a number of years ago which had a disastrous effect on his mental health. Being threatened with and then being taken to court has a huge impact on a person already suffering from a chronic illness and of course, this now happening again (with NO provocation) is dragging it all up and increasing stress levels all over again. 

Peter, and the organisations that he is involved with, must be shown up for what they really are. They do NOT care about patients or consumers or even their own members, they do not care about cannabis or the future of the industry, they do not care about the truth and they do not care about YOU!

Patients and consumers alike need to be informed and protected and we have legal access to cannabis therapeutics for patients in the UK to advance.
Not only are they bringing disrepute into the whole future of cannabis, they are also getting in the way of effective change! 


Jon Liebling - jon@liebling.co.uk





Monday, 30 October 2017

Cannatech - London October 2017

Cannatech - London October 2017


Hey Upeeps - Time for an update on Cannatech - Please Keep the information limited to ADMIN for the time being - will be writing an update for wader sharing in due course - this is just for this group and hopefully will interest and excite you!

Lousy acoustics, crap location for parking and our stand was a post!
I'd just put all the stuff I was carrying down and 3 strangers approached to start asking questions about United Patients Alliance and it carried on like that all day. Food was excellent - Kosher was a popular option, of course.

The free food and bar in the evening left a slightly bitter taste - profit and entertainment before patients?? We basically were the Patient voice in this conference - Glad we were there - we need to be - lots of good people - lots of sharks!

Abby will need to update on her connections - anyone up for taking UPA to South Africa with her?

Vital Hids

Best speaker - 19/20 yr old Dutch Cronhs Patient (with a new CBD business) - He shared his story for the first time in his life. If that's his first - good speaker. He's got a great presentation on Cannabis and Cronhs - he wants to meet up and see one of our events - maybe copy UPA for or for promotion in Holland?

Tikun Olam

Met with Tikun Olam - They had read everything on our website - everything - They said they have an affinity and empathy for what we are doing as they started out many years ago as a bunch of patients wanting to drive more research and get more effective products to patients.
They took a bunch of risks is investing in Patient Data - they started with surveys that led to better ones and ultimately to collecting data from All their patients and began to design "human trials - acceptable academic levels of control and cohort size (20 patients - 3 months data, then another, and another) - When All these companies finally realised that for approving any other medicine - a scientific  double blind study will always be the best - but for cannabis - it is so more personal and so more complex that ONLY their data gave medical professionals the information they needed to get more effective products to patients more quickly - They are now the more respected and most needed cannabis organisation in Isreal -  everyone needs what they have produced for patient care!

They would like to share pretty much everything they can "commercially" with UPA - We are the ONLY organisation in the UK they are really interested in helping (selling product - excepted)  - because they are focused on patients needs and patients care - they have a London office now - we shall get an invite soon - they might be able to provide some of their trial data and are keen to help us make our website information as good as the best in the world (in their opinion)

In addition - they happen to produce their own range of CBD products they would quite like to launch in the UK

Medipen!

The very first approach we got - two rather large, smart and a little pushy chaps, Jordan Owen (matey, chatty) and Sam Asante (focused, serious) - quite a double act actually - They want one or two or a few? of us to their offices and lab and spend half a day or more checking then out in whatever way we wish - "open book" visit.
They talked about some of the mistakes they have made and why they have invested £1.5m in research and innovation. They showed some comms with the MHRA - and a few other little gems casting doubt on some other people and organisations.
They are either really cool and have been completely misjudged - OR - they are worse than the worst!
Steve Moore and Gavin are going to do a bit of digging there - I think we should accept their hospitality and go check em out? - Who wants to come?

Saving Sophie/Cannakids

www.savingsophie.org
www.cannakids.org
CEO and Founder Tracey Ryan is happy to share everything they have as we see fit - lots of research and good info - also has live medical advice from qualified US nurses who cover paediatrics too - she was lovely - her daughter was diagnosed with brain cancer at age 8 - her mum tried oil in addition to her chemo. She's now in remission. Tracey wants to share with the world.


Besides those and at Cannatech we also had offers of assistance from:

Material assistance (money) from:

Medipen
FCM Global - Columbian Hemp/CBD grower
Zev Barnett - mavenhemp.com - THC Free products (I have some to test??)
HempIre - Did have a UK +THC license - innovating - wants to help us help make change happen in the UK - Just had license revoked with no explanation
Harmony - French based CBD Company looking for new partners.
There were one or two others who said they would be in touch to give us some cash - won't hold my breath - but you never know?

Data/advice/marketing from:

T.H.Consulting & Genetic Developments - Israel
Prohibition Partners - all their "Cannabis around the world data is ours to use - they might like to collaborate on creating more together - www.prohibitionpartners.com
Sam Blacklock - www.texerepublishing.com - publishing/marketing help and advice
Rudi Morgan - Australia based Social Media Marketing - will give free support
Dr Gratziela Lazarov - www.naturesgiftcbd.com - A qualified medical doctor from US - wants to help in many ways - she would like to throw us a fundraiser, share her info/research/data - provide qualified advice/opinion - helping engage with doctors in the UK - looking to set up a local company to help distribute her CBD products - the chap who is helping her do that wants to help us too.

The conference itself, whilst good for UPA was rather too heavy on business and light on investors - the city folk are getting interested but this didn't catch them right - Steve and Gavin have some ideas to make an investor event for UPA rather better - WIP

I'll be working through that list over the next few weeks to see if any of them deliver :)
Let me know if 1: You wanna get involved 2: Any questions about anything.

Jon

Thursday, 12 October 2017

UPA - Patients at Parliament - Media

UPA | Media Roundup


Vice (UK) - 11 October 2017
The World News - 11 October 2017
Lib Dem MP Layla Moran (pictured) admitted taking drugs at a protest to get cannabis legalised for medicinal purposes today An MP has...
35-year-old politician came to give her support to Labour MPs Tonia Antoniazzi and Paul Flynn who are trying to get cannabis made legal for
The Malay Mail Online - 11 October 2017
LONDON, Oct 11 — Several British lawmakers joined medical marijuana proponents for a “tea party” outside parliament yesterday, amid renewed......
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Breitbart - 10 October 2017
London (AFP) – Several British lawmakers joined medical marijuana proponents for a “tea party” outside parliament on Tuesday, amid renewed......
. advertisement Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists
The Citizen - 10 October 2017
Several British lawmakers joined medical marijuana proponents for a “tea party” outside parliament on Tuesday, amid renewed efforts in...
Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the lunchtime
The Sun Daily - 11 October 2017
Supporters hold placards promoting the use of cannabis as a medicine, during a 'Tea Party' organised by the United Patients Alliance (UPA),......
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
ENCA - 10 October 2017
LONDON – Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on Tuesday, amid renewed...
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
France 24 (EN) - 10 October 2017
LONDON (AFP) - Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on Tuesday, amid renewed......
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Jamaica Observer - 10 October 2017
LONDON, United Kingdom (AFP) — Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on...
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Yahoo! News Philippines - 10 October 2017
Tea pot: Labour MP Paul Flynn and Liberal Democrat colleague Layla Moran at the 'Tea Party', with food and drink containing cannabis More......
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
AFP.com (EN) - 10 October 2017
Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on Tuesday, amid renewed efforts in...
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
RFI - English - 10 October 2017
By AFP Issued on 10-10-2017 Modified 10-10-2017 to 19:40 Several British lawmakers joined medical marijuana proponents for a "tea party"...
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Yahoo! Singapore News - 9 October 2017
Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on Tuesday, amid renewed efforts in...
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Yahoo! New Zealand - News - 9 October 2017
London (AFP) - Several British lawmakers joined medical marijuana proponents for a "tea party" outside parliament on Tuesday, amid renewed......
purposes. Opposition Labour MPs Paul Flynn and Tonia Antoniazzi, with Liberal Democrat colleague Layla Moran joined other activists at the
Health Medicine Network - 10 October 2017
LONDON (Reuters) – Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
for me. It means that I actually have a life,” Hobday said. Faye Jones, a 33-year-old executive assistant and an organizer of the tea party
100.7 MIX-FM - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Business Insider - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Reuters US News - 10 October 2017
A man smokes a cannabis cigarette at a legalise cannabis tea party outside the Houses of Parliament, in London, Britain October 10, 2017....
for me. It means that I actually have a life,” Hobday said. Faye Jones, a 33-year-old executive assistant and an organizer of the tea party
93.9 WTBX - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
with just cannabis." Tuesday's protest was arranged by the United Patients Alliance, a group that has campaigned for many years on the
Investing.com UK - 10 October 2017
Yahoo! News UK - 10 October 2017
99.9 Radio USA - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Channel NewsAsia - 10 October 2017
Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday, protesting against...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Reuters India - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Netscape ISP - 10 October 2017
10/10/2017 10:00 LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament...
for me. It means that I actually have a life," Hobday said. Faye Jones, a 33-year-old executive assistant and an organizer of the tea party
94.3 Jack FM - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
94.1 Duke FM - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
with just cannabis." Tuesday's protest was arranged by the United Patients Alliance, a group that has campaigned for many years on the
KFGO The Mighty 790 - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
for me. It means that I actually have a life," Hobday said. Faye Jones, a 33-year-old executive assistant and an organizer of the tea party
101 WIXX - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
for me. It means that I actually have a life," Hobday said. Faye Jones, a 33-year-old executive assistant and an organizer of the tea party
AM 650 WNMT Northern Minnesota Talk - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
to a motion being submitted later in the day by veteran lawmaker Paul Flynn of the opposition Labour Party that aims to change legislation
Nasdaq.com - 10 October 2017
LONDON, Oct 10 (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,......
with just cannabis." Tuesday's protest was arranged by the United Patients Alliance, a group that has campaigned for many years on the
Reuters UK - 10 October 2017
Mix 92.9 - 10 October 2017
LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday,...
with just cannabis." Tuesday's protest was arranged by the United Patients Alliance, a group that has campaigned for many years on the
Yahoo Finance UK - 10 October 2017
Daily Mail Online - 10 October 2017
Daily Mail Online - 10 October 2017
Thisismoney.co.uk - 10 October 2017
Mail On Sunday - 10 October 2017
Daily Mail (eClips Web) - 10 October 2017
Eastern Daily Press - 10 October 2017
The World News - 10 October 2017
MPs and activists gathered outside Parliament for a “cannabis tea party” demanding the legalisation of the drug for medicinal purposes....
(MS), the Labour MPs Paul Flynn and Tonia Antoniazzi appeared alongside the Liberal Democrat MP Layla Moran. Sitting at the head of table
The Independent - 10 October 2017
WOW.com - 10 October 2017
Cannabis was smoked just yards from MPs today as campaigners called for the drug to be legalised for medicinal use. Activists from the...
whatsoever apart from the giggles. Fraser, who is party of the United Patients Alliance, said being forced to act as a criminal in order to
The Huffington Post (United Kingdom) - 10 October 2017
Telegraph.co.uk - 10 October 2017
The Telegraph (eClips Web) - 10 October 2017
Hempyreum.org - 10 October 2017
GETTY IMAGES Right now, hundreds of UK citizens are staging what is perhaps one of the most civil forms of civil disobedience imaginable.......
lives for the better. In the background, members of the United Patients Alliance are waving pro-cannabis banners, signs and hemp plants on
BuzzFeed - 10 October 2017
"The law is an ass," said Labour MP Paul Flynn.
seeking to change the law. He was joined by Liberal Democrat MP Layla Moran in his effort to persuade the government to allow patients with
The Independent (eClips Web) - 10 October 2017
Agerpres Foto - 10 October 2017
epa06256511 A man wears a t-shirt promoting marijuana for medical use outside the Houses of Parliament in London, Britain, 10 October 2017.......
tea and cakes containing cannabis. British Labour Mermber of Parliament Paul Flynn, is pushing for a private members bill to legalize
Naver - 10 October 2017
Cannabis tea party outside the Houses of Parliament A man smokes cannabis during a tea party outside the Houses of Parliament in London,...
tea and cakes containing cannabis. British Labour Mermber of Parliament Paul Flynn, is pushing for a private members bill to legalize
Hievents - 10 October 2017
Watton and Swaffham Times - 10 October 2017
Politico Europe - 10 October 2017
By JACK BLANCHARD Send tips here | Subscribe for free | View in your browser Good Tuesday morning. DRIVING THE DAY SHOCK JOCK:...
sufferers are expected to attend the demo, along with Labour MPs Paul Flynn and Tonia Antoniazzi. The MPs are not expected to *actually* get
Mirror.co.uk - 9 October 2017
Mirror Online (eClips Web) - 9 October 2017
The Blog - Huffington Post - 29 September 2017

Jon Liebling – Political Director of United Patients Alliance


Join us/Follow Us/Like Us/Help Us.
Facebook Twitter YouTube Instagram Website


United Patients Alliance Website